Literature DB >> 21051750

Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation.

Mariana Murea1, Barry I Freedman, John S Parks, Peter A Antinozzi, Steven C Elbein, Lijun Ma.   

Abstract

Cellular toxicity mediated by lipids (lipotoxicity) has been implicated in the pathophysiology of metabolic syndrome and diabetes mellitus. Genetic analyses now implicate lipotoxicity in susceptibility to type 2 diabetes mellitus-associated nephropathy (T2DN), a pathway that had previously been unexplored. A genome-wide association study in Japanese patients identified a single nucleotide polymorphism in the acetyl-CoA carboxylase β (ACACB) gene associated with T2DN. Replication analyses suggest that this same polymorphism may be a diabetic nephropathy risk allele in other ethnic groups. The ACACB gene (also called ACC2 or acetyl-CoA carboxylase 2) plays a critical role in intracellular fatty acid (FA) oxidation. This manuscript reviews the physiology of FA metabolism and adverse cellular effects that can result from dysregulation of this process. It is hypothesized that glomerular and tubular dysfunction can be induced by increases in intracellular FA concentrations, a process that may be enabled by genetic risk variants. This novel glucolipotoxicity hypothesis in T2DN warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051750     DOI: 10.2215/CJN.08160910

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  34 in total

1.  Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in rats.

Authors:  Lakhwinder Singh; Surbhi Rana; Sidharth Mehan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-10-29

2.  Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Mariana Murea; Lijun Ma; James D Otvos; Jolyn Turner; Peter A Antinozzi; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Michael V Rocco; John S Parks
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

3.  Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.

Authors:  S E Trasino; X-H Tang; J Jessurun; L J Gudas
Journal:  Diabetes Obes Metab       Date:  2015-12-23       Impact factor: 6.577

Review 4.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

5.  Overexpression of heart-type fatty acid binding protein enhances fatty acid-induced podocyte injury.

Authors:  Qing Gao; Alhossain Sarkar; Yizhi Chen; Bo Xu; Xiaojuan Zhu; Yang Yuan; Tianjun Guan
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

Review 6.  Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.

Authors:  Mariana Murea; Lijun Ma; Barry I Freedman
Journal:  Rev Diabet Stud       Date:  2012-05-10

7.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

8.  Relative Hypoxia and Early Diabetic Kidney Disease in Type 1 Diabetes.

Authors:  Carissa Vinovskis; Lu-Ping Li; Pottumarthi Prasad; Kalie Tommerdahl; Laura Pyle; Robert G Nelson; Meda E Pavkov; Daniel van Raalte; Marian Rewers; Marlon Pragnell; Farid H Mahmud; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  Diabetes       Date:  2020-07-31       Impact factor: 9.461

9.  Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.

Authors:  Shiran Udi; Liad Hinden; Brian Earley; Adi Drori; Noa Reuveni; Rivka Hadar; Resat Cinar; Alina Nemirovski; Joseph Tam
Journal:  J Am Soc Nephrol       Date:  2017-08-31       Impact factor: 10.121

10.  Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.

Authors:  M Y Kim; J H Lim; H H Youn; Y A Hong; K S Yang; H S Park; S Chung; S H Ko; S H Koh; S J Shin; B S Choi; H W Kim; Y S Kim; J H Lee; Y S Chang; C W Park
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.